The Future of Swedish & Danish Life Science
30th March 2017
–How are Sweden and Denmark concreting collaborations together to becoming more internationally competitive and putting us back on the map?
In the past 10-15 years, Medicon Valley has grown to be the strongest Nordic life science cluster due to a thriving life science industry and strong collaboration between Sweden and Denmark.
There have been many success stories that have put Medicon Valley on the international map with four big pharmaceutical companies Novo Nordisk, H. Lundbeck, Ferring and LEO Pharma, and there is a new wave of biotech companies that emerged around the turn of the millennium plus the science park Medicon Village celebrating their 5th year.
We certainly have a number of successful companies within the Nordics, with successful bio banks, cell therapy initiatives and clinical research which has not been growing so the trend has just recently turned positive again after the number trials dropped in 2007.
2016 has been a turbulent year both economically, politically and within the world of pharmaceuticals with reimbursements payments reducing but how does the future of the life science sector look in Sweden and Denmark?
We have our Life Science Co-ordinator Anders Lönnberg attending and very much looking forward to seeing what updates he is going to be giving from the Swedish Government. Denmark now has a growth team but we hope by the time of attending this event they will be able give more information on their strategy.
Both countries have funding available in terms of grants, angel investors and venture capital but this is certainly not being tapped into. Do we need to have more entrepreneurial agility and willingness to fail like our American friends and maybe this could be the answer to our future?
At this meeting we would like to get a cohesive message that we are collaborating – from North to the very south – and putting Scandinavia back on the map for Life Sciences so we look forward to having you with us on Thursday 30th March.
Some 35 exhibitors and 400 visitors are expected at this annual international networking forum organized by Kemivärlden Biotech/Journal of Chemistry & Biotechnology, Medicon Village and Medicon Valley Allliance. The target audience are decision makers in the pharma, biotech, medtech and healthcare sectors, R&D-persons from the industry and academia. Other targeted groups are investors, authorities and politicians. New for this fifth edition of the event is that partnering meetings will be facilitated by our one-to-one meeting partnering software available for all delegates at The Future of Swedish & Danish Life Science. We charge no entry fee and will provide lunch and refreshments. The day will be covered by the press.
We hope you will be able to join us for the end of show drinks and refreshments reception, which provides a great opportunity to network with fellow delegates. Combined with the extended lunch break and coffee breaks, delegates will have ample opportunities to touch base on a more informal basis.
Interview with the Organizer
March 30th, 2017
Medicon Village AB (Restaurang Inspira)
Scheelevägen 2, Lund
one-on-one partnering meeting system
Our one-on-one meeting system will open March 6th.
Please make sure that you have filled in your personal and company profile. This is necessary to enable other participants to search you and find you in the system and thus be able to make meeting requests with you. The system will be open for submitting requests until 10.00 PM. on March 30th. Only mutual availability between delegates will be scheduled.
8.00 Registration, partnering meetings and networking at the exhibition
8.45 Welcome and introduction, Kemivärlden Biotech/ Journal of Chemistry & Biotechnology and Anette Orheim, More coffee brings more good – meetings create the dynamic at Medicon Village Science Park
9.00 Where is Swedish Life Science Heading?
Anders Lonnberg, Life Science Swedish Government
9.20 The State of Medicon Valley
Petter Hartman, Medicon Valley Alliance
9.30 Where is SwedenBIO Nordic Life Science Days – a program update
Björn Ursing, SwedenBIO
9.40 Building an IP position that is attractive to investors and partners – establishing both your own IP and your FTO
Chris Milton, J A Kemp
10.00 The role of the institutes in the innovation process – creating value for our partners
Christine Svärd, SP
10.20 Coffee, partnering meetings and networking at the exhibition
10.40 Not what, but how – our way to success
Anne-Marie Wenthzel, Sprint Bioscience
11.00 Current trends in drug development from a service provider’s perspective
Anna Törner and Gösta Hiller, SDS
11.20 The Connected Incubator
Ebba Fåhraeus, SmiLe Incubator
11.45 Building and funding a global biotech
Diana Muftic, Novo Seeds
12.00 Cell Therapy initiative together with Region Skåne and Lund University
Kerstin Jakobsson, Medicon Village
12.10 Lunch, partnering meetings and networking at the exhibition
13.00 Dragons Den
Dragons: Hakan Goker, Merck Ventures
13.30 BioVentureHub – a different type of industry incubator
Magnus Björsne, AstraZeneca Bio Venture Hub
13.50 How can Scandinavia be best in class?
Jennie Ekbeck, Umeå Biotech Incubator
14.05 Oslo Cancer Cluster: How we work and collaborate
Ketil Widerberg, Oslo Cancer Cluster
14.20 GREAT Britain and Sweden: life science and healthcare opportunities for collaboration between hot-beds of excellence
Lucy Robertshaw, in collaboration with Harriet Fear, One Nucleus
14.30 6D’s shaping the future of work
Nicola Millard, BT
14.50 Coffee, partnering meetings and networking at the exhibition
15.20 The challenge of building fruitful collaborations in breakthrough science
Anna Sandström, AstraZeneca
15.40 Drug Research without borders – Open Innovation in Pharma
Niclas Nilsson, LEO Pharma
16.00 The Nordic Mentor Network for Entrepreneurship – how to leverage a great knowledge potential
Peter Birk, accelerace.dk
16.30 Panel debate – Are we heading in the right direction?
Invest in Skane, AZ and Swecare
Lucy Robertshaw, Lucy J Robertshaw
17.00-18.30 End of show drinks and refreshments reception
At 17.30 NASDAQ Closing Bell Ceremony during the reception!
Registration and booking please contact customer service
+46 (0)8 670 41 50
Program and partnering, please contact Managing Director Ndumbe Öhman
+46 (0)8 670 41 86
Regarding the exhibition and shipping, please contact Anders Arehag
+46 (0)736 82 53 78
As part of Future of Swedish and Danish Life Science, we understand that networking is a big part of this event which is why we are going to invite you to a breakfast and workshop on Friday 31st March at Medicon Village.
The breakfast is now fully booked.
8.30 – 12.30, Friday 31st March, Medicon Village
Title:What are the challenges of international business development in the life sciences and what are the possible collaboration opportunities in the UK and Canada? Follow up from the day before and how can we build on our relationships?
8.30 Breakfast mingle
9.00 Global Pharma Consulting
9.10 Tuba Yamac, BCF, Quebec Canada
9.30 Dave Russell Graham, Invest Essex
9.50 Greer Deal, Global Regulatory Services
10.20 Kathryn Simpson, KathrynSimpson
10.40 Nima Jokilaakso, Swecare
11.00 Maria Ahrén, Invest in Skåne
11.20-12.30 Introduction from Anette Orheim and Medicon Village tour of the facility plus information for new building project.
Kemivärlden Biotech med Kemisk Tidskrift/Journal of Chemistry & Biotechnology is the leading magazine in the Nordics with a focus on Chemistry, Biotechnology and Life Science. We are a subscription-based glossy magazine published 8 times per year. Ever since the magazine was founded in 1887, our core values have been credibility and quality. The Journal of Chemistry & Biotechnology reaches the members of SwedenBIO, Swedish Chemical Society, SwedNanoTech and other important groups associated with the biotech and Life Science industry.
Late February every year we publish our magazine in English for an international audience. To read the e-version of the international issue of 2015 please click here.
For current news and more information see the website: www.kemivarldenbiotech.se. On the website you also find a calendar covering the most important seminars, trade fairs and events. Our collaboration with international partners opens up for delgates from all over the world at our 6 annual international events.
Maria Eriksson is the initiator and Managing Director for The Future of Swedish & Danish Life Science. She holds a MSc in Medical Biology from Linköping University. Maria has a current position as Business Development Manager at Journal of Chemistry & Biotechnology (Kemivärlden Biotech) and has more than 12 years experience from the Life Science Industry. She has a background from the pharma industry and Karolinska Hospital where she served as a Research Engineer in the Fertility Unit.
Maria is also the initiator and Program Director of other international annual events such as New Updates in Drug Formulation & Biovailability in Copenhagen, Are We on Track? in Stockholm, Bioscience – Research Through innovative Technologies in Uppsala, Pharma Outsourcing – Find The Right Partner in Stockholm and New Horizons in Bioprocessing in Stockholm.
Medicon Village want to create an environment where research, innovation and entrepreneurship work together to create value for people’s health and wellbeing.
Together with the medical research centres Biomedical Centre (BMC) in Lund and the Clinical Research Centre (CRC) in Malmö, as well as the developing research facilities ESS and the MAX IV laboratory, Medicon Village is establishing an infrastructure of world class. The total area available for letting within Medicon Village amounts to around 80,000 square meters, of which laboratories account for about 30,000 square meters.
Medicon Valley Alliance (MVA) is a network organization working for the life science companies and institutions in the south of Sweden and the Copenhagen area – Medicon Valley. As a non-profit member organization, MVA carry out initiatives on behalf of the life science community aiming to support the creation of new research and business opportunities within the region. Furthermore, MVA serves as the point of entry to Medicon Valley for foreign stakeholders. MVA’s members include biotech, medtech and pharma companies, CROs and CMOs, as well as universities, science parks, investors, public organizations and various business service providers.
March 31st, 2017
Medicon Village AB (Restaurang Inspira)
Scheelevägen 2, Lund
Username and password for the one-on-one partnering meeting system will be e-mailed to you when the system is available for bookings from March 6th. Please do note that you need to register for the event first on this website.